Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-center, Randomized, Parallel-control, Superiority Study Comparing Administration of Clotting Factor Concentrates With a Standard Massive Hemorrhage Protocol in Severely Bleeding Trauma Patients.

NCT04534751 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04534751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04534751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-center, Randomized, Parallel-control, Superiority Study Comparing Administration of Clotting Factor Concentrates With a Standard Massive Hemorrhage Protocol in Severely Bleeding Trauma Patients.
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Unknown status
Start date
April 1, 2021
Completion date
January 30, 2024
Enrollment
350 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coagulopathy, massive hemorrhage, traumatic hemorrhage